Abstract

BackgroundDysregulation of long noncoding RNAs (lncRNAs) has been linked to various human cancers. Bcr-Abl oncogene that results from a reciprocal translocation between human chromosome 9 and 22, is associated with several hematological malignancies. However, the role of lncRNAs in Bcr-Abl-induced leukemia remains largely unexplored.MethodsLncRNA cDNA microarray was employed to identify key lncRNAs involved in Bcr-Abl-mediated cellular transformation. Abl-transformed cell survival and xenografted tumor growth in mice were evaluated to dissect the role of imatinib-upregulated lncRNA 1 (IUR1) in Abl-induced tumorigenesis. Primary bone marrow transformation and in vivo leukemia transplant using lncRNA-IUR1 knockout (KO) mice were further conducted to address the functional relevance of lncRNA-IUR1 in Abl-mediated leukemia. Transcriptome RNA-seq and Western blotting were performed to determine the mechanisms by which lncRNA-IUR1 regulates Bcr-Abl-induced tumorigenesis.ResultsWe identified lncRNA-IUR1 as a critical negative regulator of Bcr-Abl-induced tumorigenesis. LncRNA-IUR1 expressed in a very low level in Bcr-Abl-positive cells from chronic myeloid leukemia patients. Interestingly, it was significantly induced in Abl-positive leukemic cells treated by imatinib. Depletion of lncRNA-IUR1 promoted survival of Abl-transformed human leukemic cells in experiments in vitro and xenografted tumor growth in mice, whereas ectopic expression of lncRNA-IUR1 sensitized the cells to apoptosis and suppressed tumor growth. In concert, silencing murine lncRNA-IUR1 in Abl-transformed cells accelerated cell survival and the development of leukemia in mice. Furthermore, lncRNA-IUR1 deficient mice were generated, and we observed that knockout of murine lncRNA-IUR1 facilitated Bcr-Abl-mediated primary bone marrow transformation. Moreover, animal leukemia model revealed that lncRNA-IUR1 deficiency promoted Abl-transformed cell survival and development of leukemia in mice. Mechanistically, we demonstrated that lncRNA-IUR1 suppressed Bcr-Abl-induced tumorigenesis through negatively regulating STAT5-mediated GATA3 expression.ConclusionsThese findings unveil an inhibitory role of lncRNA-IUR1 in Abl-mediated cellular transformation, and provide new insights into molecular mechanisms underlying Abl-induced leukemogenesis.

Highlights

  • Dysregulation of long noncoding RNAs has been linked to various human cancers

  • LncRNA‐imatinib-upregulated lncRNA 1 (IUR1) is a novel lncRNA whose expression is low in Bcr‐Abl‐positive leukemic cells but highly induced by imatinib To identify key long noncoding RNAs involved in Bcr-Abl-mediated tumorigenesis, an lncRNA microarray was employed to analyze the expression of lncRNAs in Bcr-Abl–positive K562 cells treated with or without the Abl kinase inhibitor imatinib

  • Numerous (See figure on page.) Fig. 1 LncRNA-IUR1 is identified as a novel lncRNA that is induced by imatinib treatment in Bcr-Abl-positive leukemic cells

Read more

Summary

Introduction

Dysregulation of long noncoding RNAs (lncRNAs) has been linked to various human cancers. The role of lncRNAs in Bcr-Abl-induced leukemia remains largely unexplored. V-Abl is the oncogene of Abelson murine leukemia virus, which contributes to the malignant transformation of mouse pre-B cells and lymphoid tumorigenesis in mice [3]. Owing to their constitutive tyrosine kinase activity, Abl oncoproteins (Bcr-Abl, v-Abl) activate a variety of signaling pathways associated with cell survival and proliferation, such as PI3K/ AKT (phosphatidylinositol 3-kinase/protein kinase B) and JAK/STAT (Janus kinase/signal transducer and activator of transcription), resulting in uncontrolled cell survival and proliferation, and the development of leukemia [4,5,6]. The biological significance and underlying mechanisms of various lncRNAs in the development of leukemia remain poorly characterized

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call